Health Care: Drugs

Amicus Therapeutics Inc (FOLD: NASDAQ)

$7.46 -0.17 | -2.23%
09/26/16 - 01:55 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 0.00 1.22M 363.00K 18.41M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 1.22M 363.00K 18.41M
Selling, General, and Administrative Expenses 47.27M 20.72M 18.89M 19.36M
Research & Development 76.94M 47.62M 41.94M 50.27M
Operating Income before D & A (EBITDA) -124.21M -67.12M -60.47M -51.23M
Depreciation & Amortization 1.83M 1.55M 1.72M 1.71M
Interest Income 929.00K 223.00K 174.00K 316.00K
Other Income - Net -1.03M -77.00K 908.00K 674.00K
Special Income / Charges -4.38M -100.00K 0.00 0.00
Total Income Before Interest Expenses (EBIT) -130.54M -68.56M -63.10M -51.94M
Interest Expense 1.58M 1.48M 46.00K 89.00K
Pre-Tax Income -132.12M -70.04M -63.15M -52.03M
Income Taxes 0.00 -1.11M -3.51M -3.25M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -132.12M -68.93M -59.63M -48.78M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -132.12M -68.93M -59.63M -48.78M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -132.12M -68.93M -59.63M -48.78M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-127.73M -68.89M -57.65M -48.78M
Preferred Dividends
Net Income Available To Common -132.12M -68.93M -59.63M -48.78M
Basic EPS from Continuing Ops. -1.20 -0.93 -1.16 -1.07
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.20 -0.93 -1.16 -1.07
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.20 -0.93 -1.16 -1.07
Basic Normalized Net Income/Share -1.16 -0.93 -1.12 -1.07
EPS fr Continuing Ops. -1.20 -0.93 -1.16 -1.07
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.20 -0.93 -1.16 -1.07
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.20 -0.93 -1.16 -1.07
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.16 -0.93 -1.12 -1.07
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with FOLD

Latest FOLD Headlines from TheStreet

More Financial News for FOLD

Press Releases for FOLD

See All Press Releases

Partner Headlines for FOLD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter